Friday, May 15, 2026 8:02:04 AM
🔍 KBLB PR Claims vs. SEC Filings: Facility Inventory Check
Earlier in the week, I reported on the discrepancies between what KBLB claims in their PRs vs what they are reporting in their SEC Filings regarding facilities.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177590454
In short, KBLB is claiming (in the PRs) to have multiple facilities, but none of them are reported in the SEC filings.
The recent SEC 10-Q quarterly financial released yesterday shows that nothing has changed. The 10-Q is completely consistent with prior filings.
Here's the breakdown:
🏢 Properties / Leases in the Q1 2026 10-Q
The filing discloses exactly the same facilities as before:
1. Ann Arbor, MI — "executive office", $2,508/year for mail, fax, and reception only (basically just an upgraded PO Box)
2. Lansing, MI — 5,000 sq. ft. R&D lab, extended through September 30, 2028, at $50,008 / $52,808 / $55,608 annually
3. Vietnam (ended) – A 6,000 sq. meter building lease signed July 1, 2021 for five years, ended in 2025.
4. Lam Dong, Vietnam (terminated) – A 700 sq. meter facility signed Jan 31, 2024, terminated during Q3 2024 — the company "does not occupy or use the facility" and impaired the asset.
5. Lam Dong, Vietnam (current) – An 80 sq. meter facility signed September 20, 2024, running through December 31, 2030, at ~$7,200/year.
That's the complete disclosed property footprint — unchanged from the FY2025 10-K.
🚨 What's Still Absent
The Q1 2026 period (January–March 2026) is precisely when the PRs claimed new facilities were made:
Jan 7, 2026 — "Kraig Labs takes possession of three mulberry fields"
Jan 12, 2026 — "Kraig Labs takes possession of third rearing center"
None of these appear anywhere in Note 4 (Right to Use Assets and Lease Liability), the balance sheet, or the capex line. Capital expenditures for the entire quarter were just $14,116 — total — on lab and office equipment.
The fact that the PRs are saying one thing and the SEC filings are saying another is a HUGE red flag.
Earlier in the week, I reported on the discrepancies between what KBLB claims in their PRs vs what they are reporting in their SEC Filings regarding facilities.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177590454
In short, KBLB is claiming (in the PRs) to have multiple facilities, but none of them are reported in the SEC filings.
The recent SEC 10-Q quarterly financial released yesterday shows that nothing has changed. The 10-Q is completely consistent with prior filings.
Here's the breakdown:
🏢 Properties / Leases in the Q1 2026 10-Q
The filing discloses exactly the same facilities as before:
1. Ann Arbor, MI — "executive office", $2,508/year for mail, fax, and reception only (basically just an upgraded PO Box)
2. Lansing, MI — 5,000 sq. ft. R&D lab, extended through September 30, 2028, at $50,008 / $52,808 / $55,608 annually
3. Vietnam (ended) – A 6,000 sq. meter building lease signed July 1, 2021 for five years, ended in 2025.
4. Lam Dong, Vietnam (terminated) – A 700 sq. meter facility signed Jan 31, 2024, terminated during Q3 2024 — the company "does not occupy or use the facility" and impaired the asset.
5. Lam Dong, Vietnam (current) – An 80 sq. meter facility signed September 20, 2024, running through December 31, 2030, at ~$7,200/year.
That's the complete disclosed property footprint — unchanged from the FY2025 10-K.
🚨 What's Still Absent
The Q1 2026 period (January–March 2026) is precisely when the PRs claimed new facilities were made:
Jan 7, 2026 — "Kraig Labs takes possession of three mulberry fields"
Jan 12, 2026 — "Kraig Labs takes possession of third rearing center"
None of these appear anywhere in Note 4 (Right to Use Assets and Lease Liability), the balance sheet, or the capex line. Capital expenditures for the entire quarter were just $14,116 — total — on lab and office equipment.
The fact that the PRs are saying one thing and the SEC filings are saying another is a HUGE red flag.
Bearish
Recent KBLB News
- Kraig Biocraft Laboratories Smashes Production Targets as New Spider Silk Batch Surges Past Expectations • GlobeNewswire Inc. • 05/26/2026 11:35:00 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/22/2026 08:30:20 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/22/2026 08:30:19 PM
- Kraig Biocraft Laboratories Highlights Technical Breakthrough of Its Immortalized Silk Gland Cell Platform • GlobeNewswire Inc. • 05/20/2026 11:35:00 AM
- Immortalized Silk Gland Cell Line Breakthrough Expands Kraig Biocraft’s Biotech Ambitions (KBLB) • IH Market News • 05/18/2026 03:12:33 PM
- Kraig Biocraft Laboratories Announces Breakthrough Creation of Immortalized Silkworm Silk Gland Cell Line with Broad Biotechnology Applications • GlobeNewswire Inc. • 05/18/2026 11:05:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 08:31:50 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/14/2026 12:14:08 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/14/2026 04:15:05 AM
- The Plastic Crisis Is Exploding and Kraig Biocraft Laboratories Has a Unique Answer • GlobeNewswire Inc. • 05/13/2026 01:05:00 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 05/11/2026 08:30:47 PM
- Kraig Biocraft Laboratories Commissions New Production Rearing Center to Support Accelerating Spider Silk Scale-Up • GlobeNewswire Inc. • 05/11/2026 11:05:00 AM
- Kraig Biocraft Laboratories Positions Itself as a Front-Runner in Spider Silk Race • GlobeNewswire Inc. • 05/07/2026 01:05:00 PM
- Kraig Biocraft Laboratories Launches April/May Production Cycle Following Record Spider Silk Output • GlobeNewswire Inc. • 05/04/2026 11:05:00 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/30/2026 09:07:15 PM
- Kraig Biocraft (KBLB) Spider Silk Production Milestone Signals Progress Toward Commercialization • IH Market News • 04/30/2026 02:54:26 PM
- Kraig Labs Clears Dual Commercialization Milestones with Record Spider Silk Production and Successful Reeling Operations • GlobeNewswire Inc. • 04/30/2026 01:20:00 PM
- Kraig Biocraft (USOTC:KBLB) Hits 50% Production Milestone — Spider Silk Push Moves Closer to Commercial Scale • IH Market News • 04/28/2026 01:51:39 PM
- Kraig Biocraft Laboratories Reports Major Progress Converting Record-Setting Spider Silk Cocoon Production into Reeled Silk • GlobeNewswire Inc. • 04/28/2026 11:05:00 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/21/2026 06:41:52 PM
- Kraig Biocraft Laboratories Advances Record Production and Begins Processing 1.8 Metric Tons of Recombinant Spider Silk Cocoons • GlobeNewswire Inc. • 04/20/2026 11:05:00 AM
- The End of Performance at Any Cost, as Spider Silk Points to a Cleaner Future • GlobeNewswire Inc. • 04/15/2026 01:15:00 PM
